ArticleThe Journal of experimental medicine2001

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.

A Dzionek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.